E4e113f6 182c 4bf8 9cc9 Cdf1fccfc996 01
Lamivudine Tablet, Film Coated
Product Images NDC 64380-711
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 64380-711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
E4e113f6 182c 4bf8 9cc9 Cdf1fccfc996 02
The text appears to be a combination of some numbers, alphabets, symbols and a medical prescription for the drug "Lamivudine" with a recommended dosage of 300 mg once daily. There is also a graph that seems to display treatment time in weeks. No further information is available to provide a more detailed description.*
E4e113f6 182c 4bf8 9cc9 Cdf1fccfc996 03
E4e113f6 182c 4bf8 9cc9 Cdf1fccfc996 04
This is a label for medication, specifically for Chlorzoxazone tablets (brand name: Lorzone). The label includes information about how to store the medication and contact information for the distributor, Strides Pharma Inc. The medication is designed to treat muscle spasms and is available by prescription only.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
